About Us
Overview
Leadership
Board of Directors
Join Our Team
Our Focus
Migraine
SMART Platform
Our Product
Our Research
Publications
Information
Press Releases
SEC Filings
Additional Resources
Contact
STS101 (Dihydroergotamine Nasal Powder) Shows Long Duration Anti-Migraine Benefit on Baseline Photophobia,Phonophobia, and Nausea: Results From the Phase 3 Double-Blind, Randomized, Placebo-Controlled SUMMIT Study
« Back
About Us
Overview
Leadership
Board of Directors
Join Our Team
Our Focus
Migraine
SMART Platform
Our Product
Our Research
Publications
Information
Press Releases
SEC Filings
Additional Resources
Contact